Liver transplantation versus surgical resection for CC meeting the Milan criteria: A propensity score analysis

Medicine (United States)

Volumn 95, Issue 52, 2016, Pages

  Shen, Jun Yi ^a   Li, Chuan ^a   Wen, Tian Fu ^a   Yan, Lv Nan ^a   Li, Bo ^a   Wang, Wen Tao ^a   Yang, Jia Yin ^a   Xu, Ming Qing ^a   Highness, Tholakkara Nazar ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatocelluar carcinoma; Liver resection; Liver transplantation; Prognosis; Propensity scoring match

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; BILIRUBIN; ENTECAVIR; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; EARLY CANCER; FEMALE; HEPATITIS B; HUMAN; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; RADIOFREQUENCY ABLATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TUMOR DIFFERENTIATION; BLOOD; CARCINOMA, HEPATOCELLULAR; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; SURVIVAL RATE;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PLATELET COUNT; PROPENSITY SCORE; SURVIVAL RATE;

EID: 85010223400     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005756     Document Type: Article

References (41)

1. Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology 2014;60:2099-108.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
3. Fan ST, Poon RT, Yeung C, et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg 2011;98:1292-300.
4. Cillo U, Vitale A, Brolese A, et al. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. J Surg Oncol 2007;95:213-20.
5. Yokoi H, Isaji S, Yamagiwa K, et al. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006;13:123-30.
6. Tanaka S, Noguchi N, Ochiai T, et al. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: rationale for partial hepatectomy as first strategy. J Am Coll Surg 2007;204:1-6.
7. Shah SA, Cleary SP, Tan JC, et al. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007;14:2608-14.
8. Lee KK, Kim DG, Moon IS, et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010;101:47-53.
9. Baccarani U, Isola M, Adani GL, et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int 2008;21:247-54.
10. Moon DB, Lee SG, Hwang S. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3cm. Dig Dis 2007;25:320-8.
11. Li C, Zhu WJ, Wen TF, et al. Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg 2014;18: 1469-76.
12. Jiang L, Liao A, Wen T, et al. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Transpl Int 2014;27:562-9.
13. Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol 2011;137:567-75.
14. D'Agostino RBJr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
15. Hsu CY, Liu PH, Lee YH, et al. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis. Ann Surg Oncol 2015;22:1324-31.
16. Sposito C, Battiston C, Facciorusso A, et al. Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma. Br J Surg 2016;103:871-80.
17. Schraiber Ldos S, de Mattos AA, Zanotelli ML, et al. Alpha-fetoprotein level predicts recurrence after transplantation in hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e2478.
18. Pinero F, Tisi Bana M, de Ataide EC, et al. Liver transplantation for hepatocellular carcinoma: evaluation of the AFP model in a multicenter cohort from Latin America. Liver Int 2016;36:1657-67.
19. Yang SL, Liu LP, Yang S, et al. Preoperative serum alpha-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. British J Surg 2016;Mar 21.
20. Li MS, Li PF, Yang FY, et al. The intracellular mechanism of alphafetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 2002;12:151-6.
21. Lu Y, Zhu M, Li W, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med 2016;20:549-58.
22. Maithel SK, Kneuertz PJ, Kooby DA, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg 2011;212:638-48.
23. Choi SB, Kim HJ, Song TJ, et al. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 2014;21:639-47.
24. Giannini EG, Savarino V, Farinati F, et al. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int 2013;33:1594-600.
25. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
26. An C, Kim DW, Park YN, et al. Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 2015;276:433-43.
27. Zhang XY, Li C, Wen TF, et al. Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: a case-control study. World J Gastroenterol 2015;21:2358-66.
28. Venkat R, Hannallah JR, Krouse RS, et al. Preoperative thrombocytopenia and outcomes of hepatectomy for hepatocellular carcinoma. J Surg Res 2016;201:498-505.
29. Zhu SL, Ke Y, Peng YC, et al. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. PLoS One 2014;9:e115834.
30. Koniaris LG, Levi DM, Pedroso FE, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg 2011;254:527-37.
31. Poon RT, Fan ST, Lo CM, et al. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007;245:51-8.
32. Shi M, Zhang CQ, Zhang YQ, et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004;28:376-81.
33. Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10cm or more) after surgical resection. Ann Surg Oncol 2007;14:2817-23.
34. Huang J, Li BK, Chen GH, et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009;13:1627-35.
35. Torzilli G, Donadon M, Belghiti J, et al. Predicting individual survival after hepatectomy for hepatocellular carcinoma: a novel nomogram from the "HCC East & West Study Group". J Gastrointest Surg 2016;20: 1154-62.
36. Li L, Wang H, Yang J, et al. Immediate postoperative low platelet counts after living donor liver transplantation predict early allograft dysfunction. Medicine (Baltimore) 2015;94:e1373.
37. Ogasawara S, Motoyama T, Suzuki E, et al. Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. Biomed Res Int 2014;20:11871-7.
38. Pang Q, Qu K, Zhang JY, et al. The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and metaanalysis. Medicine (Baltimore) 2015;94:e1431.
39. Pang Q, Qu K, Bi JB, et al. Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: systematic review and metaanalysis. World J Gastroenterol 2015;21:7895-906.
40. Nobuoka D, Kato Y, Gotohda N, et al. Postoperative serum alphafetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma. Oncol Rep 2010;24:521-8.
41. Zhou L, Rui JA, Wang SB, et al. Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection. J Surg Oncol 2007;95:298-303.